Clinical Trial Update: METIMMOX-2: Metastatic pMMR/MSS Colorectal Cancer - Shaping Anti-Tumor Immunity by Oxaliplatin [Phase 2]

View source ↗

Summary

Phase 2 METIMMOX-2 is evaluating an oxaliplatin-based strategy to shape anti-tumor immunity in metastatic pMMR/MSS colorectal cancer; the trial is currently act…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: University Hospital, Akershus | Conditions: Colorectal Adenocarcinoma, Mucinous Adenocarcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING